ROYAL BANK OF CANADA - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 20 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,000
-50.0%
1,256
-13.2%
0.00%
Q1 2024$4,000
-78.9%
1,447
-78.3%
0.00%
Q4 2023$19,000
+171.4%
6,676
+118.4%
0.00%
Q3 2023$7,000
-46.2%
3,057
+60.3%
0.00%
Q2 2023$13,000
-55.2%
1,907
+18.6%
0.00%
Q1 2023$29,000
-49.1%
1,608
-40.5%
0.00%
Q4 2022$57,000
+533.3%
2,702
+259.3%
0.00%
Q3 2022$9,0000.0%752
+10.1%
0.00%
Q2 2022$9,000
-59.1%
683
-36.8%
0.00%
Q1 2022$22,000
-71.1%
1,081
-71.2%
0.00%
Q4 2021$76,000
-62.4%
3,758
-43.4%
0.00%
Q3 2021$202,000
+16.1%
6,644
+10.9%
0.00%
Q2 2021$174,000
-45.6%
5,991
-19.1%
0.00%
Q1 2021$320,000
+20.8%
7,406
+29.2%
0.00%
Q4 2020$265,000
+113.7%
5,734
+100.3%
0.00%
Q3 2020$124,000
+85.1%
2,862
+126.8%
0.00%
Q2 2020$67,000
+6600.0%
1,262
+2978.0%
0.00%
Q1 2020$1,000
-83.3%
41
-90.0%
0.00%
Q4 2019$6,000412
+20500.0%
0.00%
Q3 2019$0
-100.0%
2
-97.8%
0.00%
Q2 2019$1,00091
+600.0%
0.00%
Q3 2018$0
-100.0%
13
-99.5%
0.00%
Q1 2018$25,0002,4000.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Logos Global Management LP 430,000$19,866,0001.70%
APIS CAPITAL ADVISORS, LLC 20,000$924,0000.89%
Avidity Partners Management LP 547,000$25,271,0000.82%
Knoll Capital Management, LLC 20,000$924,0000.63%
Artemis Investment Management LLP 1,013,448$46,839,0000.49%
AlphaCentric Advisors LLC 25,000$1,155,0000.48%
First Light Asset Management, LLC 94,202$4,352,0000.32%
Ikarian Capital, LLC 150,000$6,930,0000.31%
Longitude (Cayman) Ltd. 8,000$370,0000.18%
AllSquare Wealth Management LLC 5,490$254,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders